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 ARTICLE INFO    ABSTRACT 
 
USP, EP, and Argentinian Pharmacopoeia proposed HPLC-UV for quantitative quality control of 
mebendazole (MBZ) tablets. In this work, a spectrophotometric method is proposed. A mebendazole 
solution was prepared by dissolving the active ingredient in an ethanolic solution of HCl (1: 100) and 
adding NaOH 3N. It was allowed to stand 10 minutes. Absorbance spectrum was scanned between 350 
and 700 nm. Maximum was found at 400 nm. A calibration curve in the range of 0.05 to 0.25 mg / mL, 
responded to A = (2.2746 ± 0.0224) C + (0.0012 ± 0.0068) with R2 = 0.9999. The RSD% was 0.961 
indicating good repeatability for the analytical procedure. Accuracy in recovery experience was found to 
be 99.2 - 100.6%. Statistical comparison using t -test and F –test indicate that there are no significant 
differences between HPLC and the spectrophometric methods, whith a 95% confidence level. Specificity 
and intermediate precision assays were satisfactory. Quantum theoretical chemistry was applied to 
elucidate the interaction that gives origin to the color, using static approximation and density functional 
theory, B3LYP and base 6-311G (d, p). Excitation energies B3LYP for MBZ and MBZ product of the 
interaction with sodium atom, were coincidental with experimental results. 
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INTRODUCTION 
 
It is estimated that 50% of the infant population of our country 
is affected by parasitosis (Espíndola, 2013). In addition, 
diseases caused by parasitic worms are one of the most 
important health problems in the world (Hotezet al., 2008). 
Benzimidazoles are anthelmintics drugs that have a broad 
spectrum of action against nematode parasites of the intestinal 
tract (Goodman and Gilman, 2003). Mebendazole is found 
within this family (Fig. 1), according to IUPAC, Methyl 
formate [(5-benzoyl-3H-benzimidazole-2-yl) amino]. This 
drug is one of the most widely used, mainly due to low 
absorption in the intestine, insignificant level of adverse 
effects, low cost, good effectiveness and absence of effects on 
intestinal microbiota (Cañete, 2009). Several techniques have 
been reported for MBZ determination. Some of them comprise 
electrochemical methods (Conesa et al, 1996; Kumar et al, 
2007; Ghalkhani et al, 2013), liquid chromatography (Mottier 
et al, 2003; Kulik et al, 2011; Ulavapalli et al, 2011; 
Santaladchaiyakit et al, 2013; Rao et al, 2014; Turabi           
et      al, 2014), chromatography  coupled to  mass    detectors 
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(Ruyck et al, 2003; Chen et al, 2011) fluorometric methods 
(Fattah et al, 1983) and Rayleigh spectroscopy (Tian et al, 
2013). As established by the Argentinian Pharmacopoeia, 
European Pharmacopoeia and USP, the official methodology 
for MBZ tablet quantification is HPLC - UV (FA, 2011; 
EDQM, 2014; USP; 2015). For routine analysis, it is desirable 
that the technique is simple, rapid and sensitive. The proposed 
method uses sodium hydroxide solutions which interact with 
the MBZ molecule and generate a yellow compound with a 
strong absorption at 400 nm. Due to a lack of bibliographic 
sources, in order to infer the formation of products that justify 
this absorption, a theoretical study of design and modeling, 
using static approximation and density functional theory, 
B3LYP and base 6-311G (d, p), was performed. 
 
Experimental 
 
Reagents and samples 
 
 Mebendazole, active ingredient: 1010812 Lot-WC, 
India origin, purity> 99.8%. 
 Mebendazole 200 mg tablets produced by 
PLAMECOR, Lot 039. 
 Excipients: white pre-compacted powder, fused silica 
and talc. 
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 Ethanol 98%, analytical grade. (Cicarelli, Argentina).
 Hydrochloric acid 38%, analytical grade (Cicarelli, 
Argentina). 
 Sodium hydroxide, analytical grade (Cicarelli, 
Argentina). 
 Potassium phosphate monobasic, analytical grade 
(Biopack, Argentina). 
 Phosphoric acid, analytical grade (Cicarelli, Argentina).
 Methanol, HPLC grade (Biopack, Argentina).
 Formic acid, analytical grade (Cicarelli, Argentina).
 
Equipment 
 
 Boeco UV-Visible Spectrophotometer S26, range 190
900 nm. 
 Agilent 1120 HPLC with UV detector of variable 
wavelength, controlled by EZ Elite Chrome software.
 Acculab precision scale, accuracy ± 0.1 mg.
 Decalab FBR Magnetic Stirrer with hot plate.
 Software Gaussian 09 package Computational 
Chemistry. 
 
 
Fig. 1. Chemical structure of mebendazole 
(C16H12N3O3, PM 295.29) 
 
Spectrophotometric Procedure 
 
For the preparation of standard solutions, 50 mg of the active 
ingredient were dissolved in 50 mL of ethanolic HCl solution 
(1: 100). Aliquots of 1 to 5 mL of this solution were 
transferred into 10 mL flasks. An appropriate amount of HCl 
solution in ethanol was added to each flask. Then 1 mL of 3 M 
NaOH was added, and diluted to the mark with distilled water. 
Solutions stood 10 min for full color development. A blank 
solution, 5 mL of ethanolic HCl solution and 1 mL of 3 M 
NaOH, brought to 10 mL with distilled water and 
homogenized, was used. The absorbance at 400 nm was 
recorded as a function of the concentration of the standards.
For sample analysis, 20 tablets were weighed and the average 
weight of one tablet was calculated (797.2 mg). Afterwards 
they were pulverized and reduced to a fine powder, yielding a 
homogeneous mixture. A mass containing the theoretical 
amount of 50 mg MBZ was dissolved and stirred, for 10 min, 
into ethanolic HCl solution (1: 100) and carried to final 
volume of 50 mL. A 10 mL aliquot was centrifuged, for 10 
min, at 2000 rpm. The above procedure was appli
aliquot of 2.5 mL of supernatant. MBZ concentration in the 
sample was determined by calibration curve. 
 
Chromatographic conditions (Official method)
 
For the mobile phase, a mixture of methanol and 50 mM 
potassium phosphate monobasic (40:60) was p
adjusted pH to 5.5 ± 0.1 with 0.1 M KOH or 0.1 M phosphoric 
acid. For the standard, 25 mg of active ingredient were 
weighed and dissolved in 10 mL of formic acid. It was carried 
to a water bath for 15 min, removed, cooled, transferred into 
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repared. Was 
100 mL volumetric flask, diluted to volume with methanol and 
homogenized. An aliquot of 5 mL of this solution was 
transferred to 25 mL flask and brought to final volume with 
mobile phase. The sample was prepared from the 
homogeneous mixture obtained by pulver
tablets. Equivalent mass to an average tablet was dissolved in 
50 mL of formic acid, heated in a water bath, stirred, cooled, 
led to final volume in 100 mL volumetric flask with distilled 
water and homogenized. An aliquot of 5 mL of this solut
was transferred to 100 mL flask, flush with a solution of 
formic acid in methanol (1: 9). The sample to be injected into 
the chromatograph was prepared with this last solution. An 
aliquot of 5 mL of the same was transferred to a 25 mL flask 
and brought to final volume with mobile phase.
18C column 125 x 4.5 mm, mobile phase flow 1.5 mL / min 
and detection at 247 nm was used. The signal corresponding to 
MBZ peak, in the standard and sample solutions were 
recorded. With the peak areas, the co
injected samples were then determined
 
Analytical Attributes and Validation
 
To determine the analytical attributes of the 
spectrophotometric method and perform validation, the 
protocol proposed by the current Pharmacopoeias [17
followed. 
 
Theoretical study of the interaction MBZ
 
In order to provide a foundation that gives support to the 
experimental evidence, manifested through 
with NaOH in the visible region of the spectrum, with 
quantitative characteristics, a theoretical study of design and 
product modeling was carried out. The calculations were 
performed with the Gaussian 09 (Frisch 
Computational Chemistry. Optimization geometries MBZ and 
more stable products found were performed using the hybrid 
version of B3LYP (Becke, 1993) and the base assembly 6
311G (d, p) [22]. The minimum more stable conformations 
were optimized again using the same functional
base, along with the continuous model (PCM) (Cossi
2003) to obtain the structure whose energy was minimal in 
solution using the same experimental solvent. Vertical 
excitation energy was determined with the most stable 
structures. A comprehensive treatment was given to the MBZ, 
product 1 and product 2 electronic excitation spectra using 
time-dependent density functional theory (TDDFT). It is 
emphasized that the Kohn–Sham (KS) molecular orbital (MO) 
method, which is the basis for the TDDFT
a MO interpretation of the ground state electronic structure and 
of the nature of the excitations.. To compare theoretical results 
with experimental data, only the theoretical energy excitation 
was considered, with the highest streng
 
RESULTS AND DISCUSSION 
 
Specificity 
 
The absorption spectra for reagent solution and reagent plus 
placebo solution were very similar to each other and showed a 
very close response to baseline (Fig. 2). Furthermore, the 
response of the reagent plus sample solution showed a 
pronounced absorbance maximum at 400 nm. The excipients 
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accompanying the formulation are chemically inert to the 
reagents used, this confirms method specificity. 
 
 
 
Fig. 2. Specificity test. Absorption spectra of solutions of reagents, 
placebo plus reagents and sample plus reagents 
 [MBZ] = 0.3 mg / mL 
 
Linearity 
 
To evaluate the linearity of the proposed method, a calibration 
curve with MBZ standard solutions was built. The obtained 
data were plotted and subjected to linear regression analysis 
(Table 1). The calibration curve fits the equation A = 2.2746 C 
+ 0.0012. The correlation coefficient of the linear fit (R2) is 
0.9999. According to the variance analysis for a 95% 
confidence level, the intercept includes the point (0, 0) (Table 
1).  
 
Table 1. Variance Analysis of the Linear Regression for MBZ-
NaOH method. Confidence level of 95% (p = 0.05) 
 
REGRESSION ANALYSIS 
Correlation coefficient, R2                           0.9999 
Intercept                                        0.0012 ± 0.0068 
Slope                                              2.2746 ± 0.0224 
 
The method was linear in the range of the studied 
concentrations. It was unnecessary to explore a wider range of 
responses since this method is proposed for quality control of 
the active ingredient. The detection limits (LOD) and 
quantification limits (LOQ), reached values of 0.009 and 0.030 
mg / mL respectively. They were calculated as follows: 
 
LOD = yA + 3. sA    Ec. 1 
 
LOQ = yA + 10. sA    Ec. 2 
 
Where:  
yA: intercept   
sA: deviation of the intercept 
 
Repeatability 
 
Twelve aliquots were analyzed. They were prepared from a 
pool of tablets belonging to the same lot (Table 2). The 
method yields a variation coefficient (CV) of 0.961%; less 
than 2%, required for such analytical determinations [4-6]. 
  
Table 2. Repeatability test for MBZ proposed method 
 
 
# 
Mass recovered 
[mg / tablet] 
MAverage 
[mg / tablet] 
S 
[mg] 
CV% 
1 198.87 200.79 1.93 0.961 
2 199.81 
3 202.13 
4 201.64 
5 204.71 
6 200.96 
7 199.37 
8 197.56 
9 200.14 
10 203.16 
11 200.66 
12 200.47 
 
Intermediate Precision 
 
The study was performed at three concentration levels, by 
adding solutions of the active ingredient over placebo. 
Different sample volumes were taken and the 
spectrophotometric method proposed for MBZ tablet was 
applied. Each analysis was performed by triplicate. Results are 
shown in Table 3, and are expressed as MBZ mass recovered 
per tablet. The overall coefficient of variation obtained in the 
intermediate precision test was less than twice the coefficient 
for repeatability (CV% GLOBAL <2 x CV% Repeatability). 
The evaluated precision showed satisfactory results [10-12]. 
 
Recovery Test 
 
The assay was performed in triplicate and at three 
concentration levels. Placebo solution enriched with different 
volumes of 1.0 mg / mL MBZ stock solution (Table 4) was 
used. The recovery is between 99.2 and 100.6%, values fall 
within the allowed ranges by current Pharmacopeia (98.0 to 
102.0%) [17-19]. 
 
Comparison between the official (HPLC – UV) and the 
proposed method 
 
The results obtained for six determinations using the official 
method are shown in Table 5. The proposed 
spectrophotometric method was compared with the official 
using Student's t test and Fisher F (Table 6). Statistically, no 
significant differences were found between the results obtained 
by both methods in determining MBZ into tablets with a 95% 
confidence level. 
 
Theoretical study results 
 
The UV-visible absorption spectra obtained in the laboratory, 
shown in Fig. 3, were used to compare the experimental results 
with theoretical results. The most probable interactions that 
arise from the comparison of theoretical study with 
experimental evidence are summarized in Table 7. For MBZ, 
theoretical wave lengths proposed by modeling are 290 nm 
and 240 nm, are very close to their experimental values (285 
and 235 nm, respectively). The products of interaction with 
sodium hydroxide that showed better agreement with 
experience are shown in Fig. 4. Product 1, corresponding to 
the interaction of the sodium atom with two nitrogen atoms of 
the MBZ molecule, has absorption peaks at 398 nm (transition 
from orbital 82 → 84, HOMO → LUMO + 1) and 270 nm 
(transition 82 → 85 orbital, LUMO HOMO → + 2).  
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Table 3. Reproducibility test for MBZ-NaOH method performed over 3 levels of concentration by two different analysts on two  
different days. Acronyms: VMBZ, volume of MBZ; MGlobal, average mass per tablet; S, standard deviation;  
and CV% percent variation coefficient 
 
VMBZ [mL] Analyst 1 Analyst 2 Reproducibility 
DAY 1 DAY 2 DAY 1 DAY 2  
1.0 mL 198.15 204.22 202.66 198.69  
199.23 202.36 197.63 200.15 
202.56 200.63 198.55 201.94 n 12 
X [mg] 199.98 202.4 199.61 200.26 X [mg]  200.56 
S [mg] 2.3 1.795 2.678 1.628 S [mg]  2.149 
CV% 1.15 0.89 1.34 0.81 CV%  1.07 
2.0 mL 198.64 203.98 202.75 203.36    
203.87 200.54 200.67 201.46   
201.34 201.01 197.96 199.64 n  12 
M [mg] 201.28 201.84 200.46 201.49 X [mg] 201.27 
S [mg] 2.615 1.865 2.402 1.86 S [mg]  1.959 
CV% 1.3 0.92 1.2 0.92 CV% 0.97 
3.0 mL 199.68 201.48 197.64 198.64    
201.67 202.63 199.82 203.64   
203.93 198.69 202.63 201.69 n  12 
M [mg] 201.76 200.93 200.03 201.32 X [mg] 201.01 
S [mg] 2.126 2.026 2.502 2.52 S [mg]  2.075 
CV% 1.05 1.01 1.25 1.25 CV% 1.03 
MGLOBAL [mg] 200.95 
SGLOBAL [mg] 2.024 
CV% GLOBAL 1.01% 
 
Table 4. Recovery test for MBZ active ingredient over placebo. Acronyms: MMBZadded, MBZ mass added; MMBZrecov, MBZ mass  
recovered; % R, percent recovery; X, average mass; S, standard deviation; and CV% percent variation coefficient 
 
MMBZadded MMBZrecov %R % R Precision 
[mg] [mg]  average Parameter Value 
1 0.995 99.5 99.2 X [mg] = 0.992 
0.988 98.8 S [mg] = 0.004 
0.992 99.2 %CV = 0.403 
2 2.036 101.8 100.6 X [mg] = 2.011 
2,021 101.1 S [mg]= 0.031 
1.977 98.9 %CV = 1.541 
3 2.965 98.8 99.9 X [mg] = 2.997 
3.009 100.3 S [mg]= 0.028 
3.016 100.5 %CV = 0.934 
 
Table 5. Determination of MBZ in tablets by HPLC-UV. Acronyms: MMBZrecov, MBZ mass recovered; MAverageRecov, MBZ  
average mass recovered; S, standard deviation; and CV% percent variation coefficient 
 
Run Signal Concentration MMBZrecov MAverageRecov S CV% 
Nº [area] [mg/mL] [mg/tablet] [mg/tablet] [mg]  
ST 2641.9 1.000 - - - - 
1 2624.4 0.993 198.67 200.24 2.045 1.021 
2 2630.8 0.996 199.15 
3 2662.6 1.008 201.56 
4 2675.8 1.013 202.56 
5 2667.9 1.010 201.96 
6 2609.8 0.988 197.56 
 
Table 6. ANOVA test results between the official method (HPLC-UV) and MBZ - NaOH spectrophotometric method.  
Confidence level of 95% (p = 0.05). Values in parentheses represent the respective critical values 
 
Parameter Method 
 Spectrophotometric  HPLC - UV 
MAverage ± S [mg] 200.46 ± 1,31  200.24 ± 2.05 
CV% 0.776  1.225 
S2 1.714  4.184 
Test F  2.441 (5.050)  
Test t  0.222 (2.228)  
 
Table 7. Results of the comparison between theoretical study and experimental data 
 
Molecule max
exp  
excit
teor  
MO Assignment 
 [nm] [nm]   
MBZ 285 290 82→83 →  
235 240 82→84 → 
Product 1 400 398 82→84 → 
260 270 82→85 → 
Product 2 400 345 82→84 → 
260 279 82→85 → 
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Figure 3. UV-visible absorption spectra of MBZ and its 
interaction product with NaOH 
 
 
 
 
 
 
Fig. 4. Interaction Products between MBZ and NaOH 
 
Meanwhile, Product 2 which arises from the interaction of 
hydroxyl with the MBZ benzene ring, has absorption peaks at 
345 nm (transition from orbital 82 → 84, HOMO → LUMO + 
1) and 279 nm (transition from orbital 82 → 85, HOMO → 
LUMO + 2). 
 
Conclusions 
 
The results allow the application of this spectrophotometric 
methodology to quantify the MBZ active ingredient in 
pharmaceutical tablets, with precision and accuracy 
comparable with the official method, without interference 
from the excipients, with clear advantages in terms of costs 
and speed of analysis, and complying with the requirements 
established by the current Pharmacopeia. Absorbance 
measurements were complemented with the application of 
theoretical chemistry, using Density functional theory, B3LYP 
and the basis 6-311G (d, p). The energies of excitations 
B3LYP for the MBZ and MBZ product interaction with 
sodium agree with the experimental results. 
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